The relationship between plasma concentration of paroxetine and CYP2D6 genotype in Japanese psychiatric patients

被引：0

作者：

Ueda, M ^{[1
]}

Hirokane, G ^{[1
]}

Morita, S ^{[1
]}

Yokono, A ^{[1
]}

Okawa, M ^{[1
]}

Shimoda, K ^{[1
]}

机构：

[1] Shiga Univ Med Sci, Otsu, Shiga 52021, Japan

来源：

EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2002年 / 12卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：S223 / S223

页数：1

共 50 条

[21] CYP2D6 genotype in psychiatric patients:: Impact on haloperidol metabolism. [J].

Schmider, J ;

Sachse, C ;

Walter, S ;

Filler, D ;

Kaiser, R ;

Roots, I ;

Brockmöller, J .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) :185-185

[22] Correction to: Relationship between plasma exposure of zolpidem and CYP2D6 genotype in healthy Korean subjects [J].

Eui Hyun Jung ;

Choong-Min Lee ;

Ji-Yeong Byeon ;

Hyo-Bin Shin ;

Kyung-Yul Oh ;

Chang-Keun Cho ;

Chang Woo Lim ;

Choon-Gon Jang ;

Seok-Yong Lee ;

Yun Jeong Lee .

Archives of Pharmacal Research, 2021, 44 :323-323

[23] Effect of CYP2D6 genotype on duloxetine serum concentration [J].

Hole, Kristine ;

Gangso, Sofie ;

Jensstuen, Asa Tonette ;

Ormoy, Hanne Holte ;

Paulsen, Maren ;

Molden, Espen ;

Haslemo, Tore .

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2024, 134 (01) :186-192

[24] Is CYP2D6 phenotype predictable from CYP2D6 genotype? [J].

Kiss, Adam Ferenc ;

Toth, Katalin ;

Juhasz, Cintia ;

Temesvari, Manna ;

Paulik, Jozsef ;

Hirka, Gabor ;

Monostory, Katalin .

MICROCHEMICAL JOURNAL, 2018, 136 :209-214

[25] Influence of CYP2D6 genotype and medication on the sparteine metabolic ratio of psychiatric patients [J].

Lohmann, PL ;

Rao, ML ;

Ludwig, M ;

Griese, EU ;

Zanger, UM ;

Mörike, K ;

Maier, W ;

Bagli, M .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 57 (04) :289-295

[26] Influence of CYP2D6 genotype and medication on the sparteine metabolic ratio of psychiatric patients [J].

P. Lohmann ;

M. Rao ;

M. Ludwig ;

E. Griese ;

U. Zanger ;

K. Mörike ;

W. Maier ;

M. Bagli .

European Journal of Clinical Pharmacology, 2001, 57 :289-295

[27] Effects of number of CYP2D6 mutated alleles on steady-state plasma concentration of paroxetine [J].

Sawamura, K ;

Suzuki, Y ;

Kawashima, Y ;

Sato, S ;

Shimoda, K ;

Someya, T .

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2003, 18 (03) :181-182

[28] Haloperidol and risperidone plasma concentration in Japanese psychiatric subjects with CYP2D6*10A,*2 and its gene duplication [J].

Ohnuma, T ;

Matsubara, Y ;

Shibata, N ;

Arai, H .

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 :S78-S78

[29] CYP2D6 genotype and phenotype relationship in South Indians [J].

Naveen, A. T. ;

Prasanna, T. ;

Farzana, B. L. ;

Rajan, S. ;

Adithan, C. .

JOURNAL OF POSTGRADUATE MEDICINE, 2006, 52 (04) :253-256

[30] Effect of CYP2D6 genotype on flecainide pharmacokinetics in Japanese patients with supraventricular tachyarrhythmia [J].

Doki, Kosuke ;

Homma, Masato ;

Kuga, Keisuke ;

Kusano, Kazutomi ;

Watanabe, Shigeyuki ;

Yamaguchi, Iwao ;

Kohda, Yukinao .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (11) :919-926

← 1 2 3 4 5 →